KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BeOne Medicines (ONC) Other Non Operating Income: 2014-2024

Historic Other Non Operating Income for BeOne Medicines (ONC) over the last 11 years, with Dec 2024 value amounting to -$12.6 million.

  • BeOne Medicines' Other Non Operating Income fell 267.69% to -$19.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$20.6 million, marking a year-over-year decrease of 215.42%. This contributed to the annual value of -$12.6 million for FY2024, which is 104.10% down from last year.
  • Latest data reveals that BeOne Medicines reported Other Non Operating Income of -$12.6 million as of FY2024, which was down 104.10% from $307.9 million recorded in FY2023.
  • BeOne Medicines' 5-year Other Non Operating Income high stood at $307.9 million for FY2023, and its period low was -$773.7 million during FY2021.
  • In the last 3 years, BeOne Medicines' Other Non Operating Income had a median value of -$12.6 million in 2024 and averaged $23.8 million.
  • In the last 5 years, BeOne Medicines' Other Non Operating Income spiked by 422.58% in 2020 and then plummeted by 2,163.67% in 2021.
  • BeOne Medicines' Other Non Operating Income (Yearly) stood at $37.5 million in 2020, then plummeted by 2,163.67% to -$773.7 million in 2021, then skyrocketed by 71.07% to -$223.9 million in 2022, then soared by 237.54% to $307.9 million in 2023, then slumped by 104.10% to -$12.6 million in 2024.